United States · FDA National Drug Code directory
Keppra XR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50474-599_38534148-3717-03b3-e063-6394a90a0f1e
- Product NDC
- 50474-599
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- levetiracetam
- Labeler
- UCB, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20090401
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVETIRACETAM — 750 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50474-599-66) · 50474-599-66
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →